Page last updated: 2024-10-27

flecainide and Myalgia

flecainide has been researched along with Myalgia in 1 studies

Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).

Myalgia: Painful sensation in the muscles.

Research Excerpts

ExcerptRelevanceReference
"Flecainide is a class 1C antiarrhythmic, which is known to cause several cardiac and non-cardiac adverse reactions."5.62Flecainide-induced myalgias and weakness: a rare adverse reaction. ( Kumar, D; Mersfelder, T; Patel, P; Rehman, ME, 2021)
"Flecainide is a class 1C antiarrhythmic, which is known to cause several cardiac and non-cardiac adverse reactions."1.62Flecainide-induced myalgias and weakness: a rare adverse reaction. ( Kumar, D; Mersfelder, T; Patel, P; Rehman, ME, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Kumar, D1
Rehman, ME1
Mersfelder, T1
Patel, P1

Other Studies

1 other study available for flecainide and Myalgia

ArticleYear
Flecainide-induced myalgias and weakness: a rare adverse reaction.
    BMJ case reports, 2021, Apr-15, Volume: 14, Issue:4

    Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Flecainide; Humans; Middle Aged; Myalgia

2021